MMA Board Approves Recommendations of the MMA’s AI Task Force

March 19, 2026

At its March 16 meeting, the MMA Board of Trustees unanimously approved the policy recommendations from the MMA’s Task Force on Artificial Intelligence in Healthcare.  

The task force was created by the Board in December 2024, in response to the growing concern about AI development, and use far outpacing regulations and moves at the federal level to deregulate AI use.  

The task force was tasked with considering the complex landscape of AI in healthcare with a focus on four key areas: transparency, the potential for bias, liability considerations, and impact on clinical decision making. Using these four areas, the task force worked for over a year to develop policy recommendations for the consideration by the Board. 

The recommendations include: 

1. Artificial intelligence is a rapidly evolving aspect of medical practice, and physicians need to be prepared to understand and, as appropriate, adapt to the changing landscape. 

1. The MMA advocates for the continued evaluation and monitoring through a state sponsored advisory committee to continually review and improve regulation of AI in healthcare.  

2. The MMA advocates for the inclusion of comprehensive AI education in medical school, post graduate curricula, and continuing professional development.  

3. The MMA supports the development of a comprehensive regulatory framework for the use of AI in healthcare.  

4. The MMA aims to monitor AI regulations that impact healthcare and educate its members on their impact.  

2. Individuals have the right to transparent, honest, and timely information pertaining to their healthcare.  

3. Physicians have a responsibility to educate themselves on AI-enabled tools utilized in their medical practice. 

1. The MMA encourages clinical uses of AI that have the potential to impact patient care, or a physician’s clinical decision, be disclosed to a patient.  

2. The MMA advocates for disclosure of the use of AI in clinical decision communications that have not been reviewed and approved by a healthcare professional.  

3. The MMA encourages specialty societies to educate their members on specific AI tools and how to best evaluate and apply them.  

4. The MMA encourages developers of AI to provide detailed information about an AI tool including, the AI’s intended uses, training data, data collection practices, and risk and discrimination mitigation strategies, to deployers of AI in an effort to promote transparency and accountability.  

5. The MMA encourages facilities to make available to their clinicians detailed information about AI tools utilized within the facility.  

4. All patients have a right to receive unbiased healthcare.  

1. The MMA supports equitable access to the benefits of AI by all patient populations. 

2. The MMA acknowledges that the use of AI in healthcare carries a considerable risk of codifying and/or exacerbating existing social inequities. 

3. The MMA acknowledges that accounting for bias in AI model design, training, and use is essential in helping to mitigate biases. 

4. The MMA encourages policies requiring rigorous and continuous evaluation of AI models for bias when they are used in the healthcare setting. 

5. The MMA expects that immediate action will be taken to correct or mitigate encountered bias. 

5. AI should not replace a physician’s recommendation for the provision of healthcare.  

1. The MMA supports efforts to ensure that healthcare professionals always make the final decision regarding the provision of healthcare.  

2. The MMA opposes coverage denial processes that utilize AI to deny coverage for a healthcare service without the meaningful input of a healthcare professional.  

3. The MMA opposes requirements from payors, hospitals, health systems, or governmental entities mandating the use of an AI tool for clinical decision making as a condition of licensure, participation, payment, or coverage.  

6. Liability for harm involving AI should be focused on the party that is in the best position to identify and mitigate the harm.  

1. The MMA acknowledges the evolving role of AI in healthcare and therefore, the evolving understanding of liability for the use of AI in healthcare. The MMA supports policies that hold physicians liable only for their own clinical decision-making. 

2. The MMA encourages multidisciplinary governance structures within systems that monitor and evaluate the performance and use of AI tools within their system and provide transparent information to clinicians within the system. 

The full task force report can be viewed here.